1. SCREENING DIAGNOSTICS OF FABRIC DISEASE AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE NORTH-WESTERN REGION OF RUSSIA
   K. A. Vishnevskii et al, 2019, Nefrologiâ (St.-Peterbg.) CrossRef
2. Restrictive cardiomyopathy in a patient with systemic sclerosis and Fabry disease: a case-based review
   Álvaro Arbeláez-Cortés et al, 2019, Rheumatol Int CrossRef
3. Metabolomic Studies of Lipid Storage Disorders, with Special Reference to Niemann-Pick Type C Disease: A Critical Review with Future Perspectives
   Benita Claire Percival et al, 2020, IJMS CrossRef
4. Long-Chain Base (LCB)-Targeted Lipidomics Study Uncovering the Presence of a Variety of LCBs in Mammalian Blood
   Mari Ohira et al, 2020, Separations CrossRef
5. Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up
   Clara Carnicer-Cáceres et al, 2021, JCM CrossRef
6. Metabolic Fingerprinting of Fabry Disease: Diagnostic and Prognostic Aspects
   Maria Teresa Rocchetti et al, 2022, Metabolites CrossRef
7. Advances in the Study of Renal Cardiac Lesions in Fabry Disease
   占渝 袁, 2023, ACM CrossRef
8. Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
   Tauben Averbuch et al, 2023, Front. Cardiovasc. Med. CrossRef
9. Modern Approach to Fabry Disease Diagnosis and Management in Children
   Olga Ya. Smirnova et al, 2024, Vopr. sovr. pediatr. CrossRef
10. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?
    Patrício Aguiar, 2024, Rare Dis Orphan Drugs J CrossRef